Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

P. Geborek

Annals of the Rheumatic Diseases · 2005 · 429 citations · 33 references

DOIFull text

Open access

Concepts

References

33